{"id":672203,"date":"2026-01-19T12:46:04","date_gmt":"2026-01-19T12:46:04","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=672203"},"modified":"2026-01-19T12:46:04","modified_gmt":"2026-01-19T12:46:04","slug":"china-depaseste-europa-in-fuziuni-si-aliante-farmaceutice-si-atrage-peste-41-de-miliarde-de-dolari","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=672203","title":{"rendered":"China dep\u0103\u0219e\u0219te Europa \u00een fuziuni \u0219i alian\u021be farmaceutice \u0219i atrage peste 41 de miliarde de dolari"},"content":{"rendered":"
<\/div>\n

\u00centr-un context \u00een care companiile farmaceutice majore caut\u0103 surse noi de inovare \u0219i echilibrare a portofoliilor de medicamente, China se impune ca destina\u021bie de top pentru alian\u021be globale. Valorile agregate ale acordurilor comerciale din biopharma cu firme chineze au dep\u0103\u0219it deja 41 p\u00e2n\u0103 la 48 miliarde de dolari<\/strong> doar \u00een prima jum\u0103tate a anului, o cifr\u0103 care \u00eentrece totalul din 2024, scrie El Economista<\/a>.<\/p>\n

Aceast\u0103 evolu\u021bie reflect\u0103 mutarea centrului de greutate al fuziunilor \u0219i achizi\u021biilor farmaceutice de la Europa c\u0103tre Asia, \u00een special c\u0103tre China<\/strong>, unde parteneriatele cu firme locale, de la startup uri de biotehnologie p\u00e2n\u0103 la companii consacrate, deschid accesul la terapii noi, tehnologii de ultim\u0103 genera\u021bie \u0219i cercetare avansat\u0103.<\/p>\n

Un factor major este avansul domeniilor inovatoare precum oncologia, imunologia \u0219i terapiile pentru obezitate<\/strong>. Acorduri uria\u0219e de licen\u021biere \u0219i colaborare \u00eentre companii occidentale, inclusiv nume de top din industria farmaceutic\u0103, \u0219i biotehnologii chineze confirm\u0103 tendin\u021ba de orientare a inov\u0103rii c\u0103tre Asia.<\/p>\n

China c\u00e2\u0219tig\u0103 teren \u00een industria global\u0103 a medicamentelor<\/h2>\n

Exist\u0103 \u0219i elemente structurale care sus\u021bin aceast\u0103 schimbare. Pia\u021ba chinez\u0103, cu peste 1,4 miliarde de poten\u021biali pacien\u021bi, ofer\u0103 un avantaj competitiv semnificativ. Sistemul de reglementare procedeaz\u0103 mai rapid la autorizarea studiilor clinice \u0219i la punerea pe pia\u021b\u0103 a tratamentelor<\/strong>, ceea ce scade costurile \u0219i accelereaz\u0103 recuperarea investi\u021biilor.<\/p>\n

Autorit\u0103\u021bile din China au simplificat accesul la studiile clinice, au redus birocra\u021bia \u0219i au scurtat termenele administrative, f\u0103c\u00e2nd lansarea unui medicament nou mai rapid\u0103 dec\u00e2t \u00een multe state occidentale. Acest ritm favorizeaz\u0103 investi\u021biile externe \u0219i atrage consor\u021bii interna\u021bionale interesate de testare \u0219i dezvoltare accelerat\u0103<\/strong>.<\/p>\n

Totu\u0219i, avansul Chinei st\u00e2rne\u0219te \u00eengrijor\u0103ri \u00eentre Europa \u0219i Statele Unite. Companiile \u0219i oficialii se tem de vulnerabilit\u0103\u021bi precum protec\u021bia propriet\u0103\u021bii intelectuale, diferen\u021bele de standarde clinice \u0219i riscul ca produc\u021bia s\u0103 se concentreze \u00eentr o singur\u0103 regiune.<\/p>\n

\u00cen acela\u0219i timp, tensiunile geopolitice, competi\u021bia pentru resurse \u0219i controlul lan\u021burilor de aprovizionare oblig\u0103 statele din Vest s\u0103 reg\u00e2ndeasc\u0103 strategiile de autonomie industrial\u0103 \u0219i medical\u0103.<\/p>\n

Europa \u00eencearc\u0103 s\u0103 recupereze decalajul<\/h2>\n

Pentru Europa, aceast\u0103 realitate vine \u00eentr-un moment critic, \u00een care blocul comunitar \u00eencearc\u0103 s\u0103 reduc\u0103 dependen\u021ba de importurile asiatice.<\/a> Se discut\u0103 politici pentru stimularea produc\u021biei interne, extinderea cercet\u0103rii \u0219i reactivarea fabricilor care au fost externalizate.<\/p>\n

Noua direc\u021bie legislativ\u0103 european\u0103 caut\u0103 s\u0103 \u00eent\u0103reasc\u0103 lan\u021burile de aprovizionare, s\u0103 asigure acces constant la medicamente esen\u021biale \u0219i s\u0103 previn\u0103 situa\u021biile critice similare celor din timpul pandemiei.<\/p>\n

Multe companii europene sunt \u00eempinse s\u0103 \u00ee\u0219i reorienteze investi\u021biile \u0219i s\u0103 dezvolte facilit\u0103\u021bi proprii de cercetare, pentru a r\u0103m\u00e2ne competitive \u00eentr o industrie care se mi\u0219c\u0103 tot mai rapid. \u00cen paralel, unele firme caut\u0103 parteneriate asiatice complementare, pentru a nu pierde ritmul.<\/p>\n

Interesul corpora\u021biilor occidentale pentru colabor\u0103ri cu parteneri chinezi nu pare a fi o tendin\u021b\u0103 trec\u0103toare, ci un semn c\u0103 direc\u021bia global\u0103 a industriei medicale intr\u0103 \u00eentr o nou\u0103 etap\u0103 economic\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00centr-un context \u00een care companiile farmaceutice majore caut\u0103 surse noi de inovare \u0219i echilibrare a portofoliilor de medicamente, China se impune ca destina\u021bie de top pentru alian\u021be globale. Valorile agregate … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":672204,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/672203"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=672203"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/672203\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/672204"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=672203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=672203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=672203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}